C37, the UAE’s first private medical workspace fully managed by Dubai Healthcare City (DHCC), has signed a partnership with the Institute of Vascular & Endovascular Sciences (IVES) at Sir Ganga Ram Hospital in India, in collaboration with healthcare advisory firm Surge Growth Partners. The agreement aims to expand specialised vascular care in the UAE through international collaboration.
Specialist surgeons to join
Under the partnership, consultant vascular and endovascular surgeons from Sir Ganga Ram Hospital will join C37 to provide advanced services in the UAE. Their expertise includes complex arterial and venous disease, advanced endovascular procedures, diabetic foot and limb salvage, carotid artery disease, and dialysis access. The collaboration also allows knowledge exchange while ensuring services are delivered within a regulated clinical workspace.
Dr. Mohamed Elbaz, Medical Director & Head of Operation at C37, said: “As UAE’s first private medical workspace designed to support both local and visiting doctors, C37 enables greater access to specialised expertise that responds to the evolving needs of the healthcare sector. This partnership further enhances C37’s role as a gateway for leading international medical expertise and attracting specialised talent, supporting innovation, and meeting the growing demand for advanced healthcare services in the UAE.”
Dr. Ajay Swaroop, Chairman of the Board of Management at Sir Ganga Ram Hospital, said: “We are delighted to know that Vascular & Endovascular Sciences, Sir Ganga Ram Hospital led by Dr. Varinder S Bedi has tied up with C37 platform by Dubai Healthcare City to provide tertiary care expertise into the UAE. We are indeed hopeful that this will expand into a bigger relationship to provide tertiary healthcare services in UAE from various other departments of our institution which is one of the oldest and reputed institution of India. I wish the very best to the team from Institute of Vascular & Endovascular Sciences, Sir Ganga Ram Hospital and also thank C37 team for providing them the platform to initiate super-specialty services in the UAE.”
Vivek Shukla, Founder & Managing Partner at SURGE Growth Partners, said: “We see this partnership as a practical step toward improving access to highly specialised vascular care in the UAE. Sir Ganga Ram Hospital brings decades of clinical depth, while C37 provides a well-governed platform for that expertise to reach patients locally. Our role at SURGE Growth Partners was to help structure this collaboration in a way that works clinically, operationally, and within the UAE healthcare framework.”
The collaboration allows C37 to connect international clinical expertise with local healthcare delivery, aiming to improve patient outcomes and support community wellbeing in the UAE.
Press Release
